+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 12Years +
All Genders
ID07733765

Study to Evaluate the Safety and Effects of Ritlecitinib for Moderate Alopecia Areata in Adolescents and Adults

Led by Pfizer · Updated on 2026-10-26

336

Participants Needed

38

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to learn about the safety and effects of a medicine called ritlecitinib for treating moderate alopecia areata AA, a condition causing patchy hair loss. The study includes participants aged 12 years and older who have had patchy hair loss for at least 6 months but not more than 10 years, without other causes of hair loss. It is a phase 3 randomized, double-blind, placebo-controlled trial designed to evaluate ritlecitinib in adolescents and adults with AA. Participants will be randomly assigned to receive either ritlecitinib 50 mg or placebo once daily by mouth for 24 weeks. After this, depending on their response, their treatment may remain the same or change to either 50 mg or 100 mg ritlecitinib for another 23 weeks. Those receiving placebo initially may also be switched to ritlecitinib during this second period. Treatments are taken at home, and the study includes multiple groups based on response to treatment. Participants will be involved for about 57 weeks, including study visits at the clinic and some phone check-ins. Researchers will monitor hair loss using the Severity of Alopecia Tool SALT and other assessments like eyebrow and eyelash evaluations, patient satisfaction, and emotional impact. Safety will be closely monitored through adverse event tracking and laboratory tests. A follow-up visit about 4 weeks after the last dose will check on participants health.

CONDITIONS

Brief Title

A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

Research Team

P

Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here